文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Mario Madoerin
发表
Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4.
W. Jahnke, P. Couttet, N. Ostermann, 2020, Journal of medicinal chemistry.